Featured Latest News

Sun Pharma Plans $1 Billion Local Debt Sale

By Uniquetimesorg September 29, 2026 0

India’s Sun Pharmaceutical Industries plans to raise around 100 billion rupees ($1.04 billion) through a rupee-denominated debt sale, according to three sources. The funds are expected to partly refinance a bridge loan taken to finance its acquisition of US healthcare company Organon & Co. Sun Pharma, India’s largest drugmaker by market value, secured a nearly […]Continue Reading

Featured Latest news

India Approves Novo Nordisk’s Wegovy for Fatty Liver Disease Treatment

By Uniquetimesorg July 18, 2026 0

India’s drug regulator has approved Novo Nordisk’s obesity drug Wegovy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease. The approval covers the 2.4 mg semaglutide injection and marks another significant milestone for the blockbuster drug, which is already approved in India for chronic weight Continue Reading

Featured Latest News

Dr Reddy’s Shares Tumble as Semaglutide Supply Disruption Raises Growth Concerns

By Uniquetimesorg July 10, 2026 0

Dr Reddy’s Laboratories recorded its worst weekly stock performance in three years after announcing disruptions in the supply of its generic semaglutide drug. The company said production of new batches had been halted due to an impurity issue in the active ingredient, with supplies expected to remain unavailable in India and disrupted in Canada until […]Continue Reading

Featured Latest News

Sun Pharma to Acquire Organon in $11.8 Billion Deal

By Uniquetimesorg April 27, 2026 0

Sun Pharmaceutical Industries has announced plans to acquire US-based Organon & Co in an all-cash deal valued at about $11.75 billion, including debt. The Indian drugmaker will purchase all outstanding shares at $14 per share, marking a premium of over 24% to Organon’s last closing price. The deal ranks among the largest overseas acquisitions by […]Continue Reading

Entertainment Featured Latest News

Sun Pharma Wins Approval to Launch Generic Wegovy in India

By Uniquetimesorg January 23, 2026 0

Sun Pharmaceutical Industries, India’s largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk’s blockbuster weight-loss drug Wegovy in India, the company said on Friday. The generic drug, semaglutide, will be launched under the brand name Noveltreat after the expiry of Novo Nordisk’s patent in March 2026. Continue Reading

Featured Latest News

Sun Pharma Launches Breakthrough Psoriasis Drug Ilumya in India

By Uniquetimesorg December 1, 2025 0

Sun Pharmaceutical Industries has introduced its blockbuster biologic therapy Ilumya (Tildrakizumab) in India, marking a major step toward expanding access to advanced treatments for moderate-to-severe plaque psoriasis. Known for selectively targeting IL-23, Ilumya has already made its mark across 35 global markets, including the United States, and is now set to benefit Continue Reading

Business Featured Latest News

Sun Pharma to Acquire U.S.-Based Checkpoint Therapeutics for $355 Million

By uniquetimes March 10, 2025 0

Sun Pharmaceutical Industries announced on Monday its acquisition of Checkpoint Therapeutics, a U.S.-based immunotherapy and targeted oncology firm, in a $355 million deal. The transaction aligns with Sun Pharma’s strategic expansion in oncology and immunotherapy, following its recent licensing agreement with Philogen for the anti-cancer drug Fibromun. The acquisition is Continue Reading

Featured Latest News

“Drug Products Adulterated”: US Regulator Warns Sun Pharma’s Gujarat Plant

By uniquetimes January 14, 2023 0

Drug giant Sun Pharma has been criticised by the US health authorities for manufacturing errors at its Gujarat-based plant, including failing to follow the proper documented procedures intended to avoid microbiological contamination of drug goods. The US Food and Drug Administration (USFDA) identified a number of violations at the Halol plant, which creates finished Continue Reading